ARTICLE | Clinical News
MOB-015: Phase III started
October 10, 2016 7:00 AM UTC
Moberg began an evaluator-blinded, European Phase II trial to compare MOB-015 vs. ciclopirox 8% nail lacquer for 48 weeks in about 400 patients. Last year, the companies partnered to develop Moberg’s ...